Inhibitory effect of biphalin and AZT on murine Friend leukemia virus infection in vitro

被引:14
作者
Tang, JL
Lipkowski, AW
Specter, S
机构
[1] Polish Acad Sci, Med Res Ctr, PL-02106 Warsaw, Poland
[2] Univ S Florida, Coll Med, Dept Med Microbiol & Immunol, Tampa, FL 33612 USA
来源
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY | 1998年 / 20卷 / 09期
关键词
biphalin; 3 '-azido-3 '-deoxythymidine; Friend leukemia virus; opioid; retrovirus;
D O I
10.1016/S0192-0561(98)00052-6
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Biphalin is a bivalent opioid analogue containing two tyrosine residues, We have examined the effect of biphalin's anti-retroviral potency in vitro using a murine model. Biphalin, in non-cytotoxic concentrations, suppressed ina dose-dependent fashion the replication of Friend leukemia virus (FLV) in Mus dunni cells as determined using a focus forming assay. FLV replication was substantially reduced by biphalin at 10(-4) M concentration, When biphalin was combined with 3'-azido-3'-deoxythymidine (AZT) the two acted synergistically in inhibiting FLV replication compared to either used alone. Using a reverse transcriptase (RT) assay, FLV RT levels also were noted to be reduced in the presence of biphalin. These observations indicate that biphalin possesses anti-retroviral activity in vitro, suggesting that this opioid peptide should be examined further in vivo to determine if it is a candidate for combined therapy with AZT and possibly other drugs for retrovirus infections including the human immunodeficiency virus (HIV). (C) 1998 International Society for Immunopharmacology. Published by Elsevier Science Ltd.
引用
收藏
页码:457 / 466
页数:10
相关论文
共 35 条
  • [1] METHOD FOR TESTING FOR SYNERGY WITH ANY NUMBER OF AGENTS
    BERENBAUM, MC
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1978, 137 (02) : 122 - 130
  • [2] CARR DB, 1995, CURRENT OPINION ANES, V8, P441
  • [3] Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection
    Cavert, W
    Notermans, DW
    Staskus, K
    Wietgrefe, SW
    Zupancic, M
    Gebhard, K
    Henry, K
    Zhang, ZQ
    Mills, R
    McDade, H
    Goudsmit, J
    Danner, SA
    Haase, AT
    [J]. SCIENCE, 1997, 276 (5314) : 960 - 964
  • [4] CHARACTERIZATION OF MOUSE MONOCLONAL-ANTIBODIES SPECIFIC FOR FRIEND MURINE LEUKEMIA VIRUS-INDUCED ERYTHROLEUKEMIA-CELLS - FRIEND-SPECIFIC AND FMR-SPECIFIC ANTIGENS
    CHESEBRO, B
    WEHRLY, K
    CLOYD, M
    BRITT, W
    PORTIS, J
    COLLINS, J
    NISHIO, J
    [J]. VIROLOGY, 1981, 112 (01) : 131 - 144
  • [5] COMBINED INTERLEUKIN 1-INTERLEUKIN-2 THERAPY OF MICE INJECTED WITH HIGHLY METASTATIC FRIEND-LEUKEMIA CELLS - HOST ANTITUMOR MECHANISMS AND MARKED EFFECTS ON ESTABLISHED METASTASES
    CIOLLI, V
    GABRIELE, L
    SESTILI, P
    VARANO, F
    PROIETTI, E
    GRESSER, I
    TESTA, U
    MONTESORO, E
    BULGARINI, D
    MARIANI, G
    PESCHLE, C
    BELARDELLI, F
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (02) : 313 - 322
  • [6] AIDS - Advances painted in shades of gray at a DC conference
    Cohen, J
    [J]. SCIENCE, 1997, 275 (5300) : 615 - 616
  • [7] HEADACHE AND ACQUIRED-IMMUNODEFICIENCY-SYNDROME
    GOLDSTEIN, J
    [J]. NEUROLOGIC CLINICS, 1990, 8 (04) : 947 - 960
  • [8] HORAN PJ, 1993, J PHARMACOL EXP THER, V265, P1446
  • [9] IDENTIFICATION OF 2 RELATED PENTAPEPTIDES FROM BRAIN WITH POTENT OPIATE AGONIST ACTIVITY
    HUGHES, J
    SMITH, TW
    KOSTERLITZ, HW
    FOTHERGILL, LA
    MORGAN, BA
    MORRIS, HR
    [J]. NATURE, 1975, 258 (5536) : 577 - 579
  • [10] JOHNSON CS, 1990, CANCER RES, V50, pS5682